-
EP3170818
European procedure
Extract from the Register of European Patents
EP About this file: EP3170818
| EP3170818 - SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 25.12.2020 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 17.01.2020 | ||
| Former | Grant of patent is intended Status updated on 27.08.2019 | ||
| Former | Request for examination was made Status updated on 22.07.2019 | ||
| Former | Grant of patent is intended Status updated on 04.03.2019 | ||
| Former | Request for examination was made Status updated on 13.02.2019 | ||
| Former | Grant of patent is intended Status updated on 01.10.2018 | ||
| Former | Request for examination was made Status updated on 01.12.2017 | ||
| Former | The application has been published Status updated on 21.04.2017 | Most recent event Tooltip | 25.12.2020 | No opposition filed within time limit | published on 27.01.2021 [2021/04] | Applicant(s) | For all designated states Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston, MA 02210 / US | [2017/21] | Inventor(s) | 01 /
KESHAVARZ-SHOKRI, Ali 4285 Corte Langostino San Diego, California 92130 / US | 02 /
ZHANG, Beili 4505 Shorepointe Way San Diego, California 92130 / US | 03 /
KRAWIEC, Mariusz 46 Littlefield Lane Marlborough, Massachusetts 01752 / US | [2020/08] |
| Former [2017/21] | 01 /
KESHAVARZ-SHOKRI, Ali 4285 Corte Langostino San Diego, CA California 92130 / US | ||
| 02 /
ZHANG, Beili 4505 Shorepointe Way San Diego, CA California 92130 / US | |||
| 03 /
KRAWIEC, Mariusz 46 Littlefield Lane Marlborough, MA Massachusetts 01752 / US | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2017/21] | Application number, filing date | 16198922.3 | 04.12.2008 | [2017/21] | Priority number, date | US20070012162P | 07.12.2007 Original published format: US 12162 P | [2017/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3170818 | Date: | 24.05.2017 | Language: | EN | [2017/21] | Type: | B1 Patent specification | No.: | EP3170818 | Date: | 19.02.2020 | Language: | EN | [2020/08] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.04.2017 | Classification | IPC: | C07D405/12, A61P11/00, A61K31/4709 | [2018/42] | CPC: |
C07D405/12 (EP,CN,KR,US);
A61K31/443 (KR);
A61K31/4709 (EP,US);
A61P1/18 (EP);
A61P11/00 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P19/08 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P27/04 (EP);
A61P3/00 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P5/16 (EP);
A61P5/50 (EP);
A61P7/04 (EP);
A61P7/12 (EP);
A61P9/00 (EP);
C07D405/08 (KR);
C07B2200/13 (US)
(-)
|
| Former IPC [2017/21] | C07D405/12, A61K31/443, A61P11/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2018/01] |
| Former [2017/21] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 24.11.2017 | BA | 24.11.2017 | RS | 24.11.2017 | Title | German: | FESTE FORMEN VON 3-(6-(1-(2,2-DIFLUORBENZO[D][1,3]DIOXOL-5-YL)-CYCLOPROPANCARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOESÄURE | [2017/21] | English: | SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID | [2017/21] | French: | FORMES SOLIDES D'ACIDE BENZOÏQUE 3-(6- (1- (2,2-DIFLUOROBENZO [D] [1,3] DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO) -3-METHYLPYRIDIN-2-YL) | [2017/21] | Examination procedure | 15.11.2016 | Date on which the examining division has become responsible | 24.11.2017 | Amendment by applicant (claims and/or description) | 24.11.2017 | Examination requested [2018/01] | 02.10.2018 | Communication of intention to grant the patent | 12.02.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 05.03.2019 | Communication of intention to grant the patent | 15.07.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 28.08.2019 | Communication of intention to grant the patent | 07.01.2020 | Fee for grant paid | 07.01.2020 | Fee for publishing/printing paid | 07.01.2020 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP08855812.7 / EP2225230 | Divisional application(s) | EP20157902.6 / EP3683218 | Opposition(s) | 20.11.2020 | No opposition filed within time limit [2021/04] | Fees paid | Renewal fee | 15.11.2016 | Renewal fee patent year 03 | 15.11.2016 | Renewal fee patent year 04 | 15.11.2016 | Renewal fee patent year 05 | 15.11.2016 | Renewal fee patent year 06 | 15.11.2016 | Renewal fee patent year 07 | 15.11.2016 | Renewal fee patent year 08 | 15.11.2016 | Renewal fee patent year 09 | 12.12.2017 | Renewal fee patent year 10 | 12.12.2018 | Renewal fee patent year 11 | 27.12.2019 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AD]WO2007056341 (VERTEX PHARMA [US], et al) | by applicant | US5304121 | US5886026 | US6099562 | WO2004028480 | WO2004080972 | WO2004091502 | WO2004110352 | WO2004111014 | WO2005035514 | WO2005049018 | US2005164973 | WO2005094374 | WO2005120497 | WO2006002421 | US6992096 | US2006035943 | WO2006044456 | WO2006044682 | WO2006044505 | WO2006044503 | WO2006044502 | US2006148864 | US2006148863 | WO2006099256 | WO2006101740 | WO2006110483 | WO2006127588 | US7202262 | WO2007044560 |